A new study published in The Lancet has found that the human papillomavirus (HPV) vaccine has reduced the risk of cervical cancer deaths among women under the age of 30 to nearly zero in the United Kingdom.
The findings are among the first major reviews of the vaccine’s long-term impact and have raised hopes that cervical cancer deaths could eventually be eliminated in countries where the HPV vaccine is widely administered.
Cervical cancer is an aggressive disease that often affects young women and generally has a poor prognosis when diagnosed at an advanced stage. HPV, which is primarily transmitted through sexual contact, is the leading cause of the disease.
The UK introduced routine HPV vaccinations for teenage girls and boys in 2008, and health experts say the latest findings demonstrate the vaccine’s remarkable effectiveness in preventing cervical cancer and saving lives.
